IE61444B1 - Process for preparing and purifying interferon - Google Patents

Process for preparing and purifying interferon

Info

Publication number
IE61444B1
IE61444B1 IE109586A IE109586A IE61444B1 IE 61444 B1 IE61444 B1 IE 61444B1 IE 109586 A IE109586 A IE 109586A IE 109586 A IE109586 A IE 109586A IE 61444 B1 IE61444 B1 IE 61444B1
Authority
IE
Ireland
Prior art keywords
leu
interferon
glu
ser
gin
Prior art date
Application number
IE109586A
Other languages
English (en)
Other versions
IE861095L (en
Inventor
Gerhard Bodo
Ingrid Maurer-Fogy
Edgar Falkner
Silvia Jutta Lindner
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IE861095L publication Critical patent/IE861095L/en
Publication of IE61444B1 publication Critical patent/IE61444B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IE109586A 1985-04-27 1986-04-25 Process for preparing and purifying interferon IE61444B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3515336A DE3515336C2 (de) 1985-04-27 1985-04-27 Verfahren zur Herstellung und Reinigung von â-Interferon

Publications (2)

Publication Number Publication Date
IE861095L IE861095L (en) 1986-10-27
IE61444B1 true IE61444B1 (en) 1994-11-02

Family

ID=6269344

Family Applications (1)

Application Number Title Priority Date Filing Date
IE109586A IE61444B1 (en) 1985-04-27 1986-04-25 Process for preparing and purifying interferon

Country Status (20)

Country Link
EP (1) EP0203382B1 (da)
JP (1) JP2566919B2 (da)
KR (1) KR940010024B1 (da)
AT (1) ATE94588T1 (da)
AU (1) AU598460B2 (da)
CA (1) CA1340281C (da)
DE (2) DE3515336C2 (da)
DK (1) DK186486A (da)
ES (1) ES8707554A1 (da)
FI (1) FI861748A7 (da)
GR (1) GR861093B (da)
HU (1) HU202883B (da)
IE (1) IE61444B1 (da)
IL (1) IL78604A (da)
NO (1) NO166727C (da)
NZ (1) NZ215969A (da)
PH (1) PH30912A (da)
PT (1) PT82452B (da)
SU (1) SU1591814A3 (da)
ZA (1) ZA863108B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
DE3813124A1 (de) * 1988-04-15 1989-10-26 Krieg Benno Destillierbare pufferloesungen und ihre anwendungen
ATE205256T1 (de) * 1994-04-09 2001-09-15 Hoffmann La Roche Verfahren zur herstellung von alpha-interferon
KR100369582B1 (ko) * 1995-09-04 2003-04-03 동아제약 주식회사 재조합알파-인터페론의정제방법
BR9915257A (pt) * 1998-11-12 2001-08-07 Schering Corp Processos de conversão de isoformas de interferon e seus produtos
ITBO20010426A1 (it) * 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
AU2003270380B2 (en) 2002-09-06 2010-07-01 Genentech, Inc. Process for protein extraction
GB0818228D0 (en) * 2008-10-06 2008-11-12 Avecia Biolog Ltd Purification process
WO2021138682A1 (en) * 2020-01-03 2021-07-08 Orpro Therapeutics, Inc. Compositions having thioredoxin activity and related methods
CN114814000B (zh) * 2022-03-30 2024-07-23 深圳科兴药业有限公司 重组人干扰素的含量检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
EP0116201B1 (en) * 1983-01-12 1992-04-22 Chiron Corporation Secretory expression in eukaryotes
DE3306060A1 (de) * 1983-02-22 1984-08-23 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung

Also Published As

Publication number Publication date
FI861748A0 (fi) 1986-04-25
DE3689008D1 (de) 1993-10-21
NO861635L (no) 1986-10-28
IE861095L (en) 1986-10-27
IL78604A (en) 1991-11-21
HU202883B (en) 1991-04-29
CA1340281C (en) 1998-12-22
AU598460B2 (en) 1990-06-28
JP2566919B2 (ja) 1996-12-25
PT82452A (de) 1986-05-01
EP0203382A3 (en) 1988-04-27
EP0203382A2 (de) 1986-12-03
FI861748L (fi) 1986-10-28
JPS61282098A (ja) 1986-12-12
DE3515336C2 (de) 1994-01-20
KR860008270A (ko) 1986-11-14
ATE94588T1 (de) 1993-10-15
GR861093B (en) 1986-08-26
NZ215969A (en) 1990-08-28
IL78604A0 (en) 1986-08-31
ES8707554A1 (es) 1987-08-01
NO166727B (no) 1991-05-21
SU1591814A3 (ru) 1990-09-07
PT82452B (pt) 1988-11-30
DK186486D0 (da) 1986-04-23
FI861748A7 (fi) 1986-10-28
PH30912A (en) 1997-12-23
HUT41073A (en) 1987-03-30
AU5677586A (en) 1986-10-30
KR940010024B1 (ko) 1994-10-20
DE3515336A1 (de) 1987-01-22
EP0203382B1 (de) 1993-09-15
ZA863108B (en) 1987-12-30
DK186486A (da) 1986-10-28
ES554372A0 (es) 1987-08-01
NO166727C (no) 1991-08-28

Similar Documents

Publication Publication Date Title
US5196323A (en) Process for preparing and purifying alpha-interferon
US4432895A (en) Monomeric interferons
US6350589B1 (en) Compositions of highly-purified natural mixtures of type I interferon derived from leukocytes and methods
JPS6267032A (ja) 組換ヒトβ―インターフェロンを含有する医薬組成物及びその製造方法
AU617656B2 (en) Purification of recombinant beta-interferon incorporating rp-hplc
JPS5813397A (ja) 免疫インタ−フエロン及びそのｍＲＮＡの製造方法
JP2955294B2 (ja) 微生物から精製され、酸化され、再生された組換えインターロイキン‐２を回収する方法
IE61444B1 (en) Process for preparing and purifying interferon
NZ203364A (en) Method for purifying human immune interferon;homogeneous human immune interferon
US4686284A (en) Production of monomeric human γ-interferon
RU2105011C1 (ru) Рекомбинантный интерлейкин 2 человека
EP0168008A2 (en) Stable composition of gamma-interferon
US4617378A (en) Purification of biologically active human immune interferon
EP0301314B1 (en) A method for the purification of interferon
Kenny et al. [64] Purification of human fibroblast interferon produced in the absence of serum by cibacron blue F3GA-agarose and high-performance liquid chromatography
JPWO1992014832A1 (ja) ヒトｂｃｄｆの精製法
AU629549B2 (en) Homogeneous dimeric m-csf and storage stable formulations thereof
MIYATA et al. Pruification of Natural Human Interferon-Gamma by Antibody Affinity Chromatography: Analysis of Constituent Protein Species in the Dimers
RU2809360C1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДА pET32a-IFG144, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ ИНТЕРФЕРОНА ГАММА, ШТАММ БАКТЕРИЙ ESCHERICHIA COLI JM109/pET32a-IFG144 - ПРОДУЦЕНТ БЕЛКА ИНТЕРФЕРОН ГАММА, СПОСОБ ПОЛУЧЕНИЯ ИНТЕРФЕРОНА ГАММА И ЛЕКАРСТВЕННОЕ СРЕДСТВО
Di Marco et al. Refolding, isolation and characterization of crystallizable human interferon-α8 expressed in Saccharomyces cerevisiae
KR920000051B1 (ko) 재조합 α-인터페론의 정제방법
Le et al. Purification and properties of a novel recombinant human hybrid interferon, σ-4 α2/α1
JPH022390A (ja) 新規なヒト顆粒球マクロファージコロニー刺激因子
JPS6144826A (ja) γ型インタ−フエロン組成物
HU201100B (en) Process for large-scale production of high purity human leukocyte alpha interferon with reduced endotoxin content and with improved therapeutic effect

Legal Events

Date Code Title Description
MM4A Patent lapsed